Search research articles
Contact Us
Filters
Showing results (121-130 of 391) with videos related to
Page
of 40
Sort By:
ACS Nano
|
July 12, 2022
Targeting the Mitochondria with Pseudo-Stealthy Nanotaxanes to Impair Mitochondrial Biogenesis for Effective Cancer Treatment
Lulu Ren, Peirong Xu, Jie Yao, et al.
European Journal of Medicinal Chemistry
|
October 29, 2025
Discovery of repurposed ethacrynic acid and its derivatives as novel TEAD inhibitors
Wei Chen, Yuqing Nan, Yiping Zhang, et al.
Science China. Life Sciences
|
March 13, 2016
Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer
Kaichao Feng, Yelei Guo, Hanren Dai, et al.
Molecular and Clinical Oncology
|
March 21, 2014
Cotargeting EGFR and autophagy signaling: A novel therapeutic strategy for non-small-cell lung cancer
Xinbing Sui, Na Kong, Minghua Zhu, et al.
IEEE Transactions on Medical Imaging
|
July 8, 2024
Attribute Prototype-Guided Iterative Scene Graph for Explainable Radiology Report Generation
Ke Zhang, Yan Yang, Jun Yu, et al.
Photodiagnosis and Photodynamic Therapy
|
April 13, 2024
Low-level photodynamic therapy in chronic wounds
Pan Chen, Yongzhen Zou, Yueling Liu, et al.
International Journal of Pharmaceutics
|
June 18, 2021
Nanodelivery of a self-assembling prodrug with exceptionally high drug loading potentiates chemotherapy efficacy
Lulu Ren, Sihang Ren, Liwei Shu, et al.
International Immunopharmacology
|
October 17, 2020
Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer
Li Yu, Xinmei Yang, Chuchu Xu, et al.
Internal Medicine (Tokyo, Japan)
|
November 5, 2010
Autologous cytokine-induced killer cells in the treatment of multiple myeloma concomitant with lung cancer and paraneoplastic dermatoses
Jie Lin, Hongli Zhu, Xuechun Lu, et al.
Signal Transduction and Targeted Therapy
|
June 27, 2018
A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer
Weidong Han, Linlin Shi, Lulu Ren, et al.
Page
of 40
Search research articles
Search
Showing results (121-130 of 391) with videos related to
Sort By:
Page
of 40
ACS Nano
|
July 12, 2022
Targeting the Mitochondria with Pseudo-Stealthy Nanotaxanes to Impair Mitochondrial Biogenesis for Effective Cancer Treatment
Lulu Ren, Peirong Xu, Jie Yao, et al.
European Journal of Medicinal Chemistry
|
October 29, 2025
Discovery of repurposed ethacrynic acid and its derivatives as novel TEAD inhibitors
Wei Chen, Yuqing Nan, Yiping Zhang, et al.
Science China. Life Sciences
|
March 13, 2016
Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer
Kaichao Feng, Yelei Guo, Hanren Dai, et al.
Molecular and Clinical Oncology
|
March 21, 2014
Cotargeting EGFR and autophagy signaling: A novel therapeutic strategy for non-small-cell lung cancer
Xinbing Sui, Na Kong, Minghua Zhu, et al.
IEEE Transactions on Medical Imaging
|
July 8, 2024
Attribute Prototype-Guided Iterative Scene Graph for Explainable Radiology Report Generation
Ke Zhang, Yan Yang, Jun Yu, et al.
Photodiagnosis and Photodynamic Therapy
|
April 13, 2024
Low-level photodynamic therapy in chronic wounds
Pan Chen, Yongzhen Zou, Yueling Liu, et al.
International Journal of Pharmaceutics
|
June 18, 2021
Nanodelivery of a self-assembling prodrug with exceptionally high drug loading potentiates chemotherapy efficacy
Lulu Ren, Sihang Ren, Liwei Shu, et al.
International Immunopharmacology
|
October 17, 2020
Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer
Li Yu, Xinmei Yang, Chuchu Xu, et al.
Internal Medicine (Tokyo, Japan)
|
November 5, 2010
Autologous cytokine-induced killer cells in the treatment of multiple myeloma concomitant with lung cancer and paraneoplastic dermatoses
Jie Lin, Hongli Zhu, Xuechun Lu, et al.
Signal Transduction and Targeted Therapy
|
June 27, 2018
A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer
Weidong Han, Linlin Shi, Lulu Ren, et al.
Page
of 40